Month: February 2022

CARLSBAD, Calif., Feb. 25, 2022 /PRNewswire/ — Recognizing the importance of providing accessible fitness solutions with options that meet the needs of all its members, EoS Fitness announced today it is building on its existing partnership with global fitness leader Les Mills to give… Click here to view original post… […]

Tillman Gerngross As market volatility sweeps through the landscape, CEO changes are really ramping up, and topping the list is Tillman Gerngross, a force in the antibody space who hitched his wagon to finding another Covid-19 solution by co-founding Adagio Therapeutics. With big investors… Click here to view original post… […]

SAN DIEGO, Feb. 24, 2022 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced recent company highlights and financial results from the fourth quarter… Click here to view original post… […]

LA JOLLA—The Salk Institute mourns the loss of Paul Farmer, MD, PhD, a champion of global health equity and recipient of the inaugural Salk Institute Medal for Health and Humanity in 2005 (now known as the Salk Medal for Public Service). Farmer died in his sleep in Rwanda… Click here to view original post… […]

SAN DIEGO, Feb. 24, 2022 /PRNewswire/ — Independa, an award-winning TV-based platform providing remote engagement, education and care, today announced the results of their second-annual commissioned survey of U.S. adults caring for their older adult parents. The results of the survey… Click here to view original post… […]

SAN DIEGO, Feb. 24, 2022 /PRNewswire/ — Epic Sciences, Inc. today announced it has partnered with Fulgent Genetics (NASDAQ:FLGT) to deliver DefineMBC comprehensive profiling results for metastatic breast cancer (MBC) patients. The partnership links Fulgent’s leading CAP/CLIA certified… Click here to view original post… […]

SAN DIEGO, Feb. 24, 2022 /PRNewswire/ — Cue Health ("Cue") (Nasdaq: HLTH), the healthcare technology company behind the country’s most accurate at-home COVID-19 test*, is partnering with three-time NBA All-Star Karl-Anthony Towns to donate $250,000 of Cue Readers and COVID-19 tests to… Click here to view original post… […]

ROTTERDAM, Netherlands and SAN DIEGO, Feb. 24, 2022 /PRNewswire/ — Today, SkylineDx announced that their Merlin Test for melanoma patients would have been able to reduce over 59% of surgery-related complications by means of deselecting patients for surgery [2]. The commercially available… Click here to view original post… […]

SAN DIEGO–(BUSINESS WIRE)–Element Biosciences partners with Dovetail Genomics to validate proximity ligation-based NGS library prep solutions on Element’s AVITI System. Click here to view original post… […]

SAN DIEGO, Feb. 23, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Feb. 23, 2022 /PRNewswire/ — Cymbiotika, a leading nutritional supplement brand known for creating pure, clinically backed supplements, today announced the launch of its Organic Longevity Mushrooms. The liposomal medicinal mushroom formula contains six powerful organic mushrooms with health benefits backed by trademarked clinical studies. The… Click here to view original post… […]

SAN FRANCISCO, LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)–Biocom California, the association representing the California life science industry, today announced that it has added Amy Butler, Ph.D., president of Biosciences at Thermo Fisher Scientific, to its board of directors and has appointed David H. Crean, Ph.D., managing partner of Coast Bioventures… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Feb. 23, 2022 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the appointment of Steve Hughes, M.D. as chief medical officer. Dr. Hughes has over 20 years of… Click here to view original post… […]